Cheng Wang, PhDUniversity of Nebraska Medical Center2015 Barbara Learned Bridge Funding Award The Hippo/YAP Signaling Pathway in Ovarian High Grade Serous Carcinoma Knowing where and how ovarian cancer starts will lead to earlier detection and better therapies. Recent studies have identified the fallopian tube secretory epithelial cell as the origin for high-grade serous ovarian carcinoma, […]
Read More
Adam Karpf, PhDUniversity of Nebraska Medical Center2018 Kirwin-Hinton Bridge Funding Award Rhno1 in High-Grade Serous Ovarian Cancer High-grade serous ovarian cancer (HGSOC) is the most common and deadly form of ovarian cancer, accounting for about 25,000 cases and 15,000 deaths in the United States every year. New and improved therapies are critically needed for HGSOC. […]
Read More
Adam R Karpf, PhDUniversity of Nebraska Medical Center 2019 Pilot Study Award Oncogenic collaboration between Cyclin E1 and FOXM1 in high-grade serous ovarian cancer High-grade serous ovarian cancer is the most common form of ovarian cancer, the most deadly gynecologic malignancy. One of the most important characteristics of HGSOC is genomic instability – when DNA […]
Read More